Tag Archives: Obamacare

Budget Options Will Reshape Healthcare

While the struggle continues in 2014 to provide effective and affordable coverage, administration and Congressional leaders will weigh a host of spending options important to coverage and delivery. Federal outlays for healthcare and health-related federal tax benefits exceed $1 trillion a year, according to the Congressional Budget Office (CBO). These and related spending on discretionary […]
Posted in Guest Blog, healthcare, Regulatory | Also tagged , , | Leave a comment

Obamacare and U.S. Pharma: Two Months In

U.S. Pharma in the Eye of the Obamacare Storm So, we’ve experienced two months of Obamacare.  How is the U.S. pharmaceutical industry doing with this new program?  I spent two weeks getting the opinions of several Rx representatives on their experience with Obamacare, as well as their thoughts on how it is impacting their marketing, […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , | 1 Comment

Single Payer Issue Will Rise Again

The future of healthcare centers on scale, population health and the value of care rather than the volume of care, according to thought leaders speaking at a leadership briefing in November in Akron, Ohio. But the political atmosphere also adds layers of complexity, they say. In order for health systems to thrive, they need to […]
Posted in Guest Blog, healthcare, Regulatory | Also tagged , , , , , | 1 Comment

Health Reform May Boost Illicit Drug Sales

Health plans that limit drug converge will encourage consumers to obtain medicines illegally, according to pharmacy experts. Marv Shepherd, director of the Center for Pharmacoeconomic Studies at the University of Texas College of Pharmacy and others noted at the Partnership for Safe Medicines Interchange in October in Washington that an increase in narrow health plan […]
Posted in compliance, healthcare, Legal, Regulatory, Safety, Strategy | Also tagged , , , | Leave a comment

The Vanishing Rx Patient Assistance Programs?

by Tom Norton In the early 1990’s, during the debate over the Clinton healthcare plan, I recall sitting in an interesting meeting at my pharma company headquarters. In response to the Clinton’s charges that the industry was “price gouging,” my firm was proposing that we provide free prescription products to any patients who could not […]
Posted in Corporate Responsibility, Guest Blog, healthcare, Legal, Market Access, Patient Communication | Also tagged , , , , , , | 1 Comment
  • Categories

  • Meta